Distinct microglia alternative splicing in Alzheimer's disease
Related Experiment Video
Updated: Aug 31, 2025

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Yanjun Lu1, Lu Tan2, Jiazhao Xie3
1Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract:
Numerous alternative splicing (AS) events have been documented in Alzheimer's disease (AD). However, cell type-specific AS analysis is still lacking. We described AS events in the hippocampal microglia sorted by CD45 and CD11b from Aβ precursor protein (APP) and non-transgenic (Ntg) mice. GSE171195 dataset was downloaded from GEO database, aligned to GRCm39 genome. Skipped exon (SE), alternative 3'SS (A3SS), retained intron (RI), alternative 5'SS (A5SS), and mutually exclusive exons (MXE) were evaluated using rMATS and maser. Differential expressed genes or transcripts were analyzed via limma. Gene ontology and correlation analyses were performed with clusterProfiler and ggcorrplot R packages. 36,340 raw counts of AS were identified, and 95 significant AS events were eventually selected with strict criteria: (1) average coverage >5; (2) delta percent spliced in >0.1. SE was the most common AS events (68.42%), followed by A3SS and RI. Autophagy genes were mainly spliced in SE events, actin depolymerization genes spliced in A3SS events, while synaptic plasticity related genes were mainly spliced in RI pattern. These significant AS events may be regulated by dysregulated splicing factors in AD. In conclusion, we revealed microglia specific AS events in AD, and our study provides novel pathological mechanisms in the pathogenesis of AD.
Insights
This study reveals cell-specific alternative splicing events in microglia from Alzheimer's disease (AD) mouse models. These findings highlight novel molecular mechanisms contributing to AD pathogenesis.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Alternative splicing (AS) is implicated in Alzheimer's disease (AD), but cell type-specific analyses are limited.
- Microglia play crucial roles in AD pathogenesis, yet their AS landscape in this disease remains underexplored.
Purpose of the Study:
- To characterize cell type-specific alternative splicing events in hippocampal microglia from an Alzheimer's disease mouse model.
- To identify novel molecular pathways and potential therapeutic targets in AD pathogenesis.
Main Methods:
- Hippocampal microglia were isolated from APP (Alzheimer's disease model) and non-transgenic mice.
- RNA sequencing data (GSE171195) were analyzed for various AS events (SE, A3SS, RI, A5SS, MXE) using rMATS and maser.
- Differential gene expression, gene ontology, and correlation analyses were performed.
Main Results:
- 95 significant AS events were identified in microglia, with skipped exons (SE) being the most prevalent type.
- Autophagy genes were predominantly affected by SE, actin depolymerization genes by alternative 3' splice sites (A3SS), and synaptic plasticity genes by retained introns (RI).
- These AS events may be driven by altered splicing factor activity in AD.
Conclusions:
- This study provides the first comprehensive analysis of microglia-specific alternative splicing in Alzheimer's disease.
- The identified AS events offer new insights into the molecular mechanisms underlying AD pathogenesis.
- These findings may pave the way for novel therapeutic strategies targeting microglia in AD.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
09:49Isolation of Region-specific Microglia from One Adult Mouse Brain Hemisphere for Deep Single-cell RNA Sequencing
Published on: December 3, 2019
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...